Ds. Straus et al., 15-deoxy-Delta(12,14)-prostaglandin J(2) inhibits multiple steps in the NF-kappa B signaling pathway, P NAS US, 97(9), 2000, pp. 4844-4849
Citations number
31
Categorie Soggetti
Multidisciplinary
Journal title
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Prostaglandin J(2)(PGJ(2)) and its metabolites Delta(12)-PGJ(2) and 15-deox
y-Delta(12,14)-PGJ(2) (15d-PGJ(2)) are naturally occurring derivatives of p
rostaglandin D-2 that have been suggested to exert antiinflammatory effects
in vivo. 15d-PGJ(2) is a high-affinity ligand for the peroxisome prolifera
tor-activated receptor gamma (pPAP gamma) and has been demonstrated to inhi
bit the induction of inflammatory response genes, including inducible NO sy
nthase and tumor necrosis factor alpha, in a PPAR gamma-dependent manner. W
e report here that 15d-PGJ(2) potently inhibits NF-kappa B-dependent transc
ription by two additional PPAR gamma-independent mechanisms. Several lines
of evidence suggest that 15d-PGJ(2) directly inhibits NF-kappa B-dependent
gene expression through covalent modifications of critical cysteine residue
s in I kappa B kinase and the DNA-binding domains of NF-kappa B subunits. T
hese mechanisms act in combination to inhibit transactivation of the NF-kap
pa B target gene cyclooxygenase 2, Direct inhibition of NF-kappa B signalin
g by 15d-PGJ(2) may contribute to negative regulation of prostaglandin bios
ynthesis and inflammation, suggesting additional approaches to the developm
ent of antiinflammatory drugs.